Fireman B.V.

Home » Fireman B.V.

IPO

Fireman B.V.

They are a clinical stage biopharmaceutical company focused on applying their proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.

Symbol

IFRX

Price Range
TBD

Anticipated Shares
6,000,000

Effective Date
November 8, 2017

Underwriters
J.P. Morgan, Leerink Partners, BMO Capital Markets

To view the prospectus for Fireman B.V. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253